These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 24361103)

  • 1. Genetic basis of myasthenia gravis - a comprehensive review.
    Avidan N; Le Panse R; Berrih-Aknin S; Miller A
    J Autoimmun; 2014 Aug; 52():146-53. PubMed ID: 24361103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in genetic predisposition of myasthenia gravis.
    Zagoriti Z; Kambouris ME; Patrinos GP; Tzartos SJ; Poulas K
    Biomed Res Int; 2013; 2013():404053. PubMed ID: 24294607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of genetic risk loci and prioritization of genes and pathways for myasthenia gravis: a genome-wide association study.
    Chia R; Saez-Atienzar S; Murphy N; Chiò A; Blauwendraat C; ; Roda RH; Tienari PJ; Kaminski HJ; Ricciardi R; Guida M; De Rosa A; Petrucci L; Evoli A; Provenzano C; Drachman DB; Traynor BJ
    Proc Natl Acad Sci U S A; 2022 Feb; 119(5):. PubMed ID: 35074870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTPN22 and myasthenia gravis: replication in an Italian population and meta-analysis of literature data.
    Provenzano C; Ricciardi R; Scuderi F; Maiuri MT; Maestri M; La Carpia F; Sferrazza A; Marino M; Leone L; Lucchi M; Mussi A; Zollino M; Evoli A; Bartoccioni E
    Neuromuscul Disord; 2012 Feb; 22(2):131-8. PubMed ID: 22197427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The autoimmunity-related polymorphism PTPN22 1858C/T is associated with anti-titin antibody-positive myasthenia gravis.
    Greve B; Hoffmann P; Illes Z; Rozsa C; Berger K; Weissert R; Melms A
    Hum Immunol; 2009 Jul; 70(7):540-2. PubMed ID: 19406179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic factors in autoimmune myasthenia gravis.
    Giraud M; Vandiedonck C; Garchon HJ
    Ann N Y Acad Sci; 2008; 1132():180-92. PubMed ID: 18567868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA class I and class II polymorphisms in Saudi patients with myasthenia gravis.
    Hajeer AH; Sawidan FA; Bohlega S; Saleh S; Sutton P; Shubaili A; Tahan AA; Al Jumah M
    Int J Immunogenet; 2009 Jun; 36(3):169-72. PubMed ID: 19490212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of HLA-DQA1*0101/2 and DQB1*0502 with myasthenia gravis in southern Iranian patients.
    Yousefipour GA; Salami Z; Farjadian S
    Iran J Immunol; 2009 Jun; 6(2):99-102. PubMed ID: 19561379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PTPN22 R620W Polymorphism is Associated with Myasthenia Gravis Risk: A Systematic Review and Meta-Analysis.
    Xiong X; Xiang M; Cheng X; Huang Y
    Med Sci Monit; 2015 Aug; 21():2567-71. PubMed ID: 26318187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA in myasthenia gravis: From superficial correlation to underlying mechanism.
    Zhong H; Zhao C; Luo S
    Autoimmun Rev; 2019 Sep; 18(9):102349. PubMed ID: 31323359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk for myasthenia gravis maps to a (151) Pro→Ala change in TNIP1 and to human leukocyte antigen-B*08.
    Gregersen PK; Kosoy R; Lee AT; Lamb J; Sussman J; McKee D; Simpfendorfer KR; Pirskanen-Matell R; Piehl F; Pan-Hammarstrom Q; Verschuuren JJ; Titulaer MJ; Niks EH; Marx A; Ströbel P; Tackenberg B; Pütz M; Maniaol A; Elsais A; Tallaksen C; Harbo HF; Lie BA; Raychaudhuri S; de Bakker PI; Melms A; Garchon HJ; Willcox N; Hammarstrom L; Seldin MF
    Ann Neurol; 2012 Dec; 72(6):927-35. PubMed ID: 23055271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myasthenia Gravis: paradox versus paradigm in autoimmunity.
    Berrih-Aknin S
    J Autoimmun; 2014 Aug; 52():1-28. PubMed ID: 24934596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A genome-wide association study of myasthenia gravis.
    Renton AE; Pliner HA; Provenzano C; Evoli A; Ricciardi R; Nalls MA; Marangi G; Abramzon Y; Arepalli S; Chong S; Hernandez DG; Johnson JO; Bartoccioni E; Scuderi F; Maestri M; Gibbs JR; Errichiello E; Chiò A; Restagno G; Sabatelli M; Macek M; Scholz SW; Corse A; Chaudhry V; Benatar M; Barohn RJ; McVey A; Pasnoor M; Dimachkie MM; Rowin J; Kissel J; Freimer M; Kaminski HJ; Sanders DB; Lipscomb B; Massey JM; Chopra M; Howard JF; Koopman WJ; Nicolle MW; Pascuzzi RM; Pestronk A; Wulf C; Florence J; Blackmore D; Soloway A; Siddiqi Z; Muppidi S; Wolfe G; Richman D; Mezei MM; Jiwa T; Oger J; Drachman DB; Traynor BJ
    JAMA Neurol; 2015 Apr; 72(4):396-404. PubMed ID: 25643325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of the PTPN22*R620W polymorphism with autoimmune myasthenia gravis.
    Vandiedonck C; Capdevielle C; Giraud M; Krumeich S; Jais JP; Eymard B; Tranchant C; Gajdos P; Garchon HJ
    Ann Neurol; 2006 Feb; 59(2):404-7. PubMed ID: 16437561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene Polymorphisms for Both Auto-antigen and Immune-Modulating Proteins Are Associated with the Susceptibility of Autoimmune Myasthenia Gravis.
    Li HF; Hong Y; Zhang X; Xie Y; Skeie GO; Hao HJ; Gilhus NE; Liang B; Yue YX; Zhang XJ; Gao X; Wang Q; Gao Z; Ding XJ; Song M
    Mol Neurobiol; 2017 Aug; 54(6):4771-4780. PubMed ID: 27501803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stromal cell derived factor-1 genetic variation at locus 801 in patients with myasthenia gravis.
    Yousefipour GA; Haghshenas MR; Yahyazadeh S; Erfani N
    Iran J Immunol; 2011 Jun; 8(2):90-5. PubMed ID: 21705836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune mechanisms in myasthenia gravis.
    Cavalcante P; Bernasconi P; Mantegazza R
    Curr Opin Neurol; 2012 Oct; 25(5):621-9. PubMed ID: 22941261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common cellular and diverse genetic basis of thymoma-associated myasthenia gravis: role of MHC class II and AIRE genes and genetic polymorphisms.
    Ströbel P; Chuang WY; Chuvpilo S; Zettl A; Katzenberger T; Kalbacher H; Rieckmann P; Nix W; Schalke B; Gold R; Müller-Hermelink HK; Peterson P; Marx A
    Ann N Y Acad Sci; 2008; 1132():143-56. PubMed ID: 18567864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered expression of miR-146a in myasthenia gravis.
    Lu J; Yan M; Wang Y; Zhang J; Yang H; Tian FF; Zhou W; Zhang N; Li J
    Neurosci Lett; 2013 Oct; 555():85-90. PubMed ID: 24036458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoimmune associations and autoantibody screening show focused recognition in patient subgroups with generalized myasthenia gravis.
    Klein R; Marx A; Ströbel P; Schalke B; Nix W; Willcox N
    Hum Immunol; 2013 Sep; 74(9):1184-93. PubMed ID: 23792059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.